As the clinical trial landscape increases in complexity, traditional clinical risk management solutions have become insufficient to meet the needs of most sponsors.
It’s really no wonder that reactive methods aren’t as effective as they once were, because sponsors (and CROs) have a lot more moving parts to deal with: